- Home
- NCV vs SCPH Comparison
NCV vs SCPH Comparison
Compare NCV & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCV
- SCPH
- Stock Information
- Founded
- NCV 2003
- SCPH 2013
- Country
- NCV United States
- SCPH United States
- Employees
- NCV N/A
- SCPH N/A
- Industry
- NCV Finance Companies
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NCV Finance
- SCPH Health Care
- Exchange
- NCV Nasdaq
- SCPH Nasdaq
- Market Cap
- NCV 336.2M
- SCPH 274.7M
- IPO Year
- NCV N/A
- SCPH 2017
- Fundamental
- Price
- NCV $3.68
- SCPH $3.58
- Analyst Decision
- NCV
- SCPH Strong Buy
- Analyst Count
- NCV 0
- SCPH 2
- Target Price
- NCV N/A
- SCPH $15.00
- AVG Volume (30 Days)
- NCV 405.1K
- SCPH 552.8K
- Earning Date
- NCV 01-01-0001
- SCPH 11-13-2024
- Dividend Yield
- NCV 12.48%
- SCPH N/A
- EPS Growth
- NCV N/A
- SCPH N/A
- EPS
- NCV N/A
- SCPH N/A
- Revenue
- NCV N/A
- SCPH $30,278,000.00
- Revenue This Year
- NCV N/A
- SCPH $174.12
- Revenue Next Year
- NCV N/A
- SCPH $133.41
- P/E Ratio
- NCV N/A
- SCPH N/A
- Revenue Growth
- NCV N/A
- SCPH 303.87
- 52 Week Low
- NCV $2.84
- SCPH $3.08
- 52 Week High
- NCV $3.59
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- NCV 63.46
- SCPH 43.17
- Support Level
- NCV $3.66
- SCPH $3.53
- Resistance Level
- NCV $3.73
- SCPH $3.82
- Average True Range (ATR)
- NCV 0.06
- SCPH 0.27
- MACD
- NCV 0.01
- SCPH 0.03
- Stochastic Oscillator
- NCV 84.85
- SCPH 54.01
About NCV Virtus Convertible & Income Fund of Beneficial Interest
Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of capital appreciation and high current income. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.